Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Merck Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Merck Canada Inc.

arrow
CPHI Shenzhen
Not Confirmed

Merck Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Doravirine

Brand Name : PIFELTRO

Patent Number : 2794377

Filing Date : 2011-03-28

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-03-28

Date Granted : 2015-06-16

blank

02

arrow
CPHI Shenzhen
Not Confirmed

Merck Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate

Brand Name : DELSTRIGO

Patent Number : 3006192

Filing Date : 2016-11-29

Strength per Unit : 100mg / 300mg / 300mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-11-29

Date Granted : 2023-11-28

blank

03

arrow
CPHI Shenzhen
Not Confirmed

Merck Canada Inc.

Country
arrow
CPHI Shenzhen
Not Confirmed

Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate

Brand Name : DELSTRIGO

Patent Number : 2794377

Filing Date : 2011-03-28

Strength per Unit : 100mg / 300mg / 300mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-03-28

Date Granted : 2015-06-16

blank